Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Non Operating Interest Expenses (2019 - 2022)

Inventiva (IVEVF) posted Non Operating Interest Expenses of -$180583.8 for Q4 2022, down 420.49% on a QoQ basis from $56345.7 in Q3 2022, and down 292.51% year-over-year from $93805.6 in Q4 2021.

Analysis

Inventiva (IVEVF) Non Operating Interest Expenses (2019 - 2022) Analysis & Trends

Inventiva has reported Non Operating Interest Expenses for 4 years, with the latest figure at -$180583.8 in Q4 2022.

  • On a quarterly basis, Non Operating Interest Expenses fell 292.51% year-over-year to -$180583.8 in Q4 2022; TTM through Dec 2022 was -$2.7 million, a 49.0% increase from a year earlier, with the FY2025 full-year figure at -$252.5 million, down 165.75% from the prior year.
  • Non Operating Interest Expenses was -$180583.8 for Q4 2022 at Inventiva, down from $56345.7 in the prior quarter.
  • The five-year high for Non Operating Interest Expenses was $93805.6 in Q4 2021, with the low at -$2.7 million in Q1 2021.
  • Average Non Operating Interest Expenses over 4 years is -$605781.6, with a median of -$30840.9 recorded in 2020.
  • The largest YoY upside for Non Operating Interest Expenses was 337.09% in 2021 against a maximum downside of 18794.71% in 2021.
  • Over 4 years, Non Operating Interest Expenses stood at -$46489.3 in 2019, then soared by 146.16% to $21461.2 in 2020, then jumped by 337.09% to $93805.6 in 2021, then plunged by 292.51% to -$180583.8 in 2022.
  • The last three Non Operating Interest Expenses figures came in at -$180583.8 (Q4 2022), $56345.7 (Q3 2022), and $93805.6 (Q4 2021), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 642.70 Bn 621.95 Bn 17.26 Bn 281.00 Mn
2 AbbVie 440.80 Bn 434.23 Bn 12.70 Bn -
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn -
4 Novartis Ag 266.37 Bn 258.68 Bn 11.24 Bn -462.00 Mn
5 Pfizer 158.89 Bn 147.19 Bn 10.94 Bn -
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn -333.60 Mn
7 Revolution Medicines 44.38 Bn 44.38 Bn - 23.78 Mn
8 Incyte 25.28 Bn 20.74 Bn 1.57 Bn 582,000.00
9 United Therapeutics 21.46 Bn 18.80 Bn 683.80 Mn 2.90 Mn
10 Inventiva 693.72 Mn 693.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -180,583.78
Sep 22, 2022 56,345.74
Dec 31, 2021 93,805.62
Jun 30, 2021 -2.64 Mn
Mar 31, 2021 -2.71 Mn
Dec 31, 2020 21,461.22
Jun 30, 2020 -30,840.88
Mar 31, 2020 -14,351.21
Dec 31, 2019 -46,489.28